日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer

一种针对Pronectin™ AXL的首创双特异性T细胞衔接器(pAXLxCD3ε),用于治疗卵巢癌

Riillo, Caterina; Polerà, Nicoletta; Di Martino, Maria Teresa; Juli, Giada; Hokanson, Craig A; Odineca, Tatjana; Signorelli, Stefania; Grillone, Katia; Ascrizzi, Serena; Mancuso, Antonia; Staropoli, Nicoletta; Caparello, Basilio; Cerra, Maria; Nisticò, Giuseppe; Tagliaferri, Pierosandro; Crea, Roberto; Caracciolo, Daniele; Tassone, Pierfrancesco

AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors

来自 3 个合成人类文库的 AXL 受体靶向 14FN3 单域蛋白 (Pronectins™) 作为探索针对实体肿瘤的新型双特异性构建体的组成部分

Craig A Hokanson, Emanuela Zacco, Guido Cappuccilli, Tatjana Odineca, Roberto Crea